Finding a new drug target to treat frontotemporal lobar degeneration

Frontotemporal lobar degeneration (FTLD) is a neurodegenerative disease affecting the frontal and temporal lobes that regulate higher cognitive brain functions such as personality, behavior, and language. FTLD-tau is characterized by Tau protein misfolding and accumulation and neuronal cell death, and despite valiant efforts by scientists worldwide, no effective treatments for disease modification are currently available.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup